Elanco Animal Health Incorporated (ELAN) — closed signal from September 1, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on November 30, 2025.
Predicted vs. what happened
What happened
Reached its target in 36 days.
The thesis — published September 1, 2025
Elanco's stock is being driven more by mood and price action than by hard numbers right now. At the end of August, the price moved above what many analysts expected over the next year, which can nudge them to raise those goals. Buying interest is strong, with lots more people buying than usual and a firm recent average price. If estimates improve and the trend holds, shares could drift higher over the next 3 months.
Primary drivers
- Price trend is up, and the recent average price remains firm and rising
- Buying interest looks stronger than usual, showing steady demand from traders
- Share price moved above many analysts' 12-month targets, drawing attention
- Analysts may raise earnings forecasts, which often supports higher prices
How it played out
ELAN: target reached in 36 days
Lyra published ELAN at $18.35 on 2025-09-01, with 17% expected growth over a short-term window. The thesis pointed to an uptrend, stronger than usual buying interest, a firm recent average price, attention from trading above many analyst targets, and possible estimate raises.
Inside the window, the stock reached the $21.47 target in 36 days. It later peaked at $23.70 on 2025-11-26, with a 29.2% gain at the high. The end price was $23.27 on 2025-11-30. The thesis played out, and the move went past the target before the window closed.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.